Health

New Clinical Data Confirms Yomi Robotic System Enhances Efficiency in Dental Implant Surgery

October 23, 2025 13:48 ET  | Source: Neocis MIAMI, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Neocis®, the leader in robotic-assisted…

2 months ago

Award-Winning Film An Inconvenient Study Sparks Global Debate on Vaccine Safety and Chronic Disease

AUSTIN, Texas, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The award-winning film An Inconvenient Study has been seen by millions following its…

2 months ago

Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report

October 23, 2025 13:08 ET  | Source: Progyny, Inc. NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq:…

2 months ago

HearAdvisor Announces New Guide on the Best Hearing Aids and Earplugs of 2025 with Expert Choice Awards

October 22, 2025 17:59 ET  | Source: HearAdvisor Rockford, Il, Oct. 22, 2025 (GLOBE NEWSWIRE) -- HearAdvisor, an independent audio…

2 months ago

CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025

October 22, 2025 16:30 ET  | Source: CVRx, Inc. MINNEAPOLIS, Oct. 22, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX)…

2 months ago

Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept Data in Primary Sjgrens Disease

October 22, 2025 16:30 ET  | Source: Vor Biopharma CAMBRIDGE, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq:…

2 months ago

Aveanna Announces Pricing of Secondary Offering of Common Stock

ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused…

2 months ago

Biomea Fusion to Participate in Citi’s SMID Biotech C-Suite Fireside Chat Series

October 21, 2025 19:05 ET  | Source: Biomea Fusion, Inc. SAN CARLOS, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Biomea…

2 months ago

Sotera Health Announces Third-Quarter 2025 Earnings Release Date

CLEVELAND, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization…

2 months ago

PIVOT-PO Phase 3 Data Show Tebipenem HBrs Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)

Data presented at IDWeek 2025 after study stopped early for efficacyPrimary endpoint met, demonstrating non-inferiority of oral tebipenem HBr compared…

2 months ago